Orthostatic Hypotension
📧 Sign up to get email alerts when something new happens for Orthostatic Hypotension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-05-31FDA Approved: FLUDROCORTISONE ACETATE — Original Application (Novitium Pharma LLC)
FDA approved the original generic application for fludrocortisone acetate (ANDA 215279) from Novitium Pharma LLC. This approval makes a gene…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Treatment of Orthostatic Hypotension [Phase 2, Phase 3]
Phase 2/3 trial update for treatment of orthostatic hypotension; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Orthostatic Hypotension Treatment on Rehab Unit [NA]
A completed clinical trial from VA investigates treatments for orthostatic hypotension and falls in a rehab setting, with results posted in …
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of droxidopa under an Original Application (ANDA 214387) from Aurobindo Pharma Limited.
-
FDA approval · 2021-01-21FDA Approved: MIDODRINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic Midodrine Hydrochloride for the treatment of orthostatic hypotension (original ANDA approval).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-10-01FDA Approved: MIDODRINE HYDROCHLORIDE — Original Application (Xiromed, LLC)
FDA approved Midodrine Hydrochloride under an original Abbreviated New Drug Application (ANDA) for Xiromed, LLC.
-
FDA approval · 2020-09-01FDA Approved: MIDODRINE HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)
FDA approved a generic version of midodrine hydrochloride from Zydus Lifesciences Limited under an original application. The product is inte…
-
FDA approval · 2020-08-10FDA Approved: MIDODRINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved MIDODRINE HYDROCHLORIDE from Aurobindo Pharma Limited as a generic drug under an Original Application (ANDA 212774).
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: RaGuS Trial by Postoperative Patients [Phase 4]
Phase 4 clinical trial update for RaGuS trial in postoperative patients; current status is unknown.
-
FDA approval · 2019-11-20FDA Approved: MIDODRINE HYDROCHLORIDE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Midodrine hydrochloride from NorthStar Rx LLC, enabling its generic product to be marketed under…
-
FDA approval · 2019-11-13FDA Approved: MIDODRINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith laboratories, LLC)
FDA approved a supplemental application for midodrine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2019-11-13FDA Approved: MIDODRINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for Apotex Corp's generic midodrine hydrochloride.
-
FDA approval · 2019-11-04FDA Approved: MIDODRINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Midodrine hydrochloride submitted by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Dawn Simulation and Postural Hypotension [Phase 4]
Phase 4 clinical trial update on dawn simulation and postural hypotension.
-
FDA approval · 2019-08-19FDA Approved: MIDODRINE HYDROCHLORIDE — Original Application (NorthStar Rx LLC)
FDA approved the original application for Midodrine Hydrochloride (generic Midodrine), used to treat orthostatic hypotension.
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Transcranial Electrical Stimulation for Management of Orthostatic Instability in Acute Cervical Spinal Cord Injury [Phase 2]
Phase 2 clinical trial assessing transcranial electrical stimulation for management of orthostatic instability in acute cervical spinal cord…
-
FDA approval · 2018-11-02FDA Approved: MIDODRINE HYDROCHLORIDE — Original Application (Umasuto, LLC)
The FDA approved a generic midodrine hydrochloride product from Umasuto, LLC under an original application (ANDA), authorizing its marketing…
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine or Intravenous Fluid Bolus in Patients Following Total Hip Arthroplasty [NA]
An open-label, terminated clinical trial evaluating midodrine versus intravenous fluid bolus to reduce signs and symptoms of orthostatic hyp…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Acetylcholinesterase Inhibition and Orthostatic Hypotension in SCI [Phase 2]
Phase 2 clinical trial investigated acetylcholinesterase inhibition with pyridostigmine to treat orthostatic hypotension in individuals with…
-
CLINICAL_TRIALS research · 2017-04-14Clinical Trial Update: Home-Based Walking Study in Older Adults With Type 2 Diabetes [NA]
A ClinicalTrials.gov update indicates a home-based walking study in older adults with Type 2 diabetes has completed, with considerations of …
-
FDA approval · 2017-02-10FDA Approved: NORTHERA — Supplemental Application (Lundbeck Pharmaceuticals LLC)
The FDA approved a supplemental application for Northera (droxidopa) submitted by Lundbeck Pharmaceuticals LLC. This action approves changes…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Treatment of Orthostatic Hypotension in Autonomic Failure [Phase 1]
A Phase 1 clinical trial at Vanderbilt University evaluating treatment for orthostatic hypotension in autonomic failure has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Posture Detection for Automated Abdominal Binder
This update reports the completion of a Vanderbilt University trial evaluating posture detection for an automated abdominal binder, with con…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
A completed clinical trial evaluated norepinephrine transporter blockade as a pathological biomarker in neurogenic orthostatic hypotension a…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Study of Pulse Pressure During Tilttable and Erigo® in Adult Patients With Acquired Brain Injury [NA]
Completed clinical trial evaluating pulse pressure during tilt-table testing and Erigo mobilization in adults with acquired brain injury.